Home Cart Sign in  
Chemical Structure| 2760481-53-4 Chemical Structure| 2760481-53-4

Structure of TNG908
CAS No.: 2760481-53-4

Chemical Structure| 2760481-53-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

TNG908 is an MTAP-cooperative PRMT5 inhibitor with strong selectivity, capable of crossing the blood-brain barrier and showing 15 times higher selectivity for MTAP-null cell lines compared to MTAP-wild type cell lines, suitable for research on MTAP-deficient related cancers.

Synonyms: Ralometostat

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of TNG908

CAS No. :2760481-53-4
Formula : C21H23N5O2S
M.W : 409.50
SMILES Code : O=C(NC1=CC(C)=C(N)N=C1)C(N2[C@@H](C3=CC=C(SC=N4)C4=C3)CC[C@H](C)C2)=O
Synonyms :
Ralometostat
MDL No. :N/A

Safety of TNG908

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of TNG908

epigenetics

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT05275478 Locally Advanced Solid Tumor PHASE1|PHASE2 ACTIVE_NOT_RECRUITING 2025-09-25 University of California Los A... More >>ngeles, Los Angeles, California, 90095, United States|University of California San Francisco, San Francisco, California, 94143, United States|Sarah Cannon Research Institute at HealthONE, Denver, Colorado, 80218, United States|Grand Valley Oncology, Grand Junction, Colorado, 81505, United States|Florida Cancer Specialists & Research Institute, Lake Mary, Florida, 32746, United States|Northwestern University, Chicago, Illinois, 60611, United States|Carle Cancer Center, Urbana, Illinois, 61801, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Washington University, Saint Louis, Missouri, 63110, United States|NYU Langone Health, New York, New York, 10016, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10022, United States|Sarah Cannon Tennessee Oncology, Nashville, Tennessee, 37203, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|NEXT Oncology, Fairfax, Virginia, 22031, United States|Institut Bergonié, Bordeaux, 33000, France|Centre Léon Bérard, Lyon, 69373, France|EDOG Institut de Cancerologie de l'Ouest, Saint-Herblain, 44805, France|Institut Oncopole Claudius Regaud, Toulouse, 31059, France|Institute Gustav Roussy, Villejuif, 94805, France Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.44mL

0.49mL

0.24mL

12.21mL

2.44mL

1.22mL

24.42mL

4.88mL

2.44mL

 

Historical Records

Categories